Cell Source, Inc.
CLCS · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $16 | $14 | $0 | $16 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $10 | $10 | $10 | $9 |
| Enterprise Value | $26 | $24 | $10 | $25 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.021 | -0.042 | -0.045 | -0.04 |
| % Growth | 49.6% | 6.5% | -12.9% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$0 |